Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCMECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HN.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.42.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HN.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.7.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.20.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.5.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.13.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JY.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCRECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.86ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GJ.1.2.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GE.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HN.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.29ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.11.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GL.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.8.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.26ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBC.1.6.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GW.5.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KC.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.5.5.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCMEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HN.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.42.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HN.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.7.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.20.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.5.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.13.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JY.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCREHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.86EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GJ.1.2.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GE.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HN.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.11.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used